Medicines360 and Allergan Present Four-Year Multi-Center Pivotal Trial Data of LILETTA (levonorgestrel-releasing intrauterine system) 52 mg at the 2017 ACOG Meeting

Source :: PR Newswire. May 9, 2017
Publication Year :: 2017
Abstract: DUBLIN and SAN FRANCISCO, May 9, 2017 /PRNewswire/ -- Allergan plc (NYSE:AGN), a leading global pharmaceutical company, and Medicines360, a nonprofit women's health pharmaceutical company with a mission of expanding [...]

Subjects :: Women -- Health aspects
Pregnancy
Contraceptive drug implants -- Product development
Levonorgestrel -- Product development
Business
News, opinion and commentary
American College of Obstetricians and Gynecologists

Tools